About the potential partner
This Chinese company was founded in 1943, is one of Asia's largest anti-inflammatory drugs producers and has an established international export base.  They are also a key local player in the cardiovascular, central nervous system and anti-infection drugs industries. Their main products are chemical raw materials, pharmaceutical preparations, chemicals, pharmaceutical intermediates with more than 300 varieties.

Cooperation demand description:
The company has a production line of chemical raw materials for solid oral dosage forms (tablets capsules, granules) and relatively smaller capacity production lines for injectable forms.  They are now looking to co-operate with foreign companies that have New or Leading anti- high blood pressure or lipid-lowering drugs for introduction to the Chinese market.

Co-operation Model:

They are open to any form of co-operation including

• In-licensing,
• Joint-venture manufacturing and sales
• Direct importing.

Expected countries (regions) for cooperation:
Europe，USA.

Companies with New or leading patented drugs or technology in the blood pressure reduction or lipid lowering field interested in China market entry please contact us quoting: REF:GL0908A-111-TR/Request for New and Leading anti- high blood pressure or lipid-lowering drugs for Chinese market

Back